Intellectual Property India Publishes Patent Application for 'Oncolytic Virus And Uses Thereof' Filed by Janssen Biotech, Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065567 A) filed by Janssen Biotech, Inc., Horsham, U.S.A., on July 9, for 'oncolytic virus and uses thereof.'

Inventor(s) include Baillat, David; Drake, Charles; Fuhrmann, Steven R.; Harvilla, Paul; Laquerre, Sylvie; Mulvey, Matthew; Sepulveda, Manuel; Shamanna, Raghavendra; Tamot, Ninkka; Taylor, Kathryne; and Yamada, Douglas.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are oncolytic viruses including payload genes, encompassing genes that encode IL-12, FLT3L, CD40 agonists, and/or CTLA-4 antibodies. Also provided are expression cassettes, pharmaceutical compositions, and methods of treatment employing these viruses. Furthermore, expression cassettes and CD40 agonist molecules are also provided in this disclosure."

The patent application was internationally filed on Dec. 19, 2023, under International application No.PCT/IB2023/062941.

Disclaimer: Curated by HT Syndication.